Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1359 CNY

100%
Buy Us a Coffee

CVE-2020-10627

Quick assessment

Affected
Insulet Omnipod Insulin Management System
Exploitation
No confirmed in-the-wild exploitation; assess based on exposure
Recommended action
Check the vendor advisory and references for a fixed version. If immediate upgrade is impossible, restrict exposure and increase monitoring.

Insulet Omnipod Insulin Management System是美国Insulet公司的一套胰岛素管理系统。 Insulet Omnipod Insulin Management System 存在安全漏洞，该漏洞源于无线射频通信协议没有正确实现身份验证或授权。 访问受影响的胰岛素泵模型之一的攻击者可能能够修改和/或拦截数据。 此漏洞还可能允许攻击者更改泵设置并控制胰岛素输送。

CVSS 7.3 · High EPSS 0.49% · P40
Get alerts for future matching vulnerabilities Log in to subscribe

I. Basic Information for CVE-2020-10627

Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: CVE Program / CVE List V5
Vulnerability Description
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
Source: CVE Program / CVE List V5
CVSS Information
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L
Source: CVE Program / CVE List V5
Vulnerability Type
访问控制不恰当
Source: CVE Program / CVE List V5
Vulnerability Title
Insulet Omnipod Insulin Management System 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Insulet Omnipod Insulin Management System是美国Insulet公司的一套胰岛素管理系统。 Insulet Omnipod Insulin Management System 存在安全漏洞，该漏洞源于无线射频通信协议没有正确实现身份验证或授权。 访问受影响的胰岛素泵模型之一的攻击者可能能够修改和/或拦截数据。 此漏洞还可能允许攻击者更改泵设置并控制胰岛素输送。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)

Affected Products

Vendor Product Affected Versions CPE Subscribe
Insulet Omnipod Insulin Management System 19191 -

II. Public POCs for CVE-2020-10627

# POC Description Source Link Shenlong Link
AI-Generated POC Premium

No public POC found.

Login to generate AI POC

III. Intelligence Information for CVE-2020-10627

请登录查看更多情报信息。

Vendor Advisories for CVE-2020-10627 (1)

Other References for CVE-2020-10627 (1)

IV. Related Vulnerabilities

Same weakness: CWE-284

V. Comments for CVE-2020-10627

No comments yet

Leave a comment